Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, December 04, 2017
Mylan and Aspen announced the U.S. launch of Myleran Injection, 60 mg/10 mL (6 mg/mL) Single-dose Vial, a generic version of Busulfex Injection.
read more
Thursday, November 30, 2017
AMRI has more than doubled its current bulk API aseptic manufacturing capacity.
read more
Wednesday, November 29, 2017
Wavelength Pharmaceuticals has hired Iftach Seri and Tami Cohen as the company’s new CEO and CFO, respectively.
read more
Wednesday, November 29, 2017
Phyton Biotech has received a grant from the Bill & Melinda Gates Foundation to fund research and development of an alternative method of producing artemisinin.
read more
Wednesday, November 22, 2017
SK Capital completed its previously announced acquisition of Perrigo Company API business.
read more
Thursday, November 16, 2017
Ionis Pharmaceuticals has licensed a second orally delivered Generation 2.5 antisense drug to Janssen Biotech for which Ionis earned $5 million.
read more
Thursday, November 16, 2017
Boehringer Ingelheim and MiNA have signed a collaboration and licensing agreement focused on the development of novel compounds to treat fibrotic liver diseases.
read more
Wednesday, November 15, 2017
Agenus announced the receipt of a $4 million payment for the advancement of an undisclosed antibody under the license and research collaboration agreement with Merck.
read more
Monday, November 13, 2017
Avista Pharma Solutions has completed facility upgrades that effectively double the company’s API manufacturing capacity at its Longmont, Colorado site.
read more
Wednesday, November 08, 2017
Cambrex announced that it has completed an expansion of cGMP small scale capacity at its Charles City, Iowa plant.
read more
Tuesday, November 07, 2017
PharmaMar announced a licensing agreement with Boryung Pharm to commercialize the marine-derived anticancer drug Zepsyre, if approved, in South Korea.
read more
Wednesday, November 01, 2017
Capsugel announced expanded clinical trial capabilities at its Edinburgh facility in Scotland.
read more
Wednesday, November 01, 2017
Moderna Therapeutics announced a new license and collaboration with AstraZeneca to co-develop and co-commercialize an mRNA therapeutic encoding for Relaxin.
read more
Tuesday, October 31, 2017
Sawai has entered into an exclusive agreement with AstraZeneca to manufacture and market Zomig Tablets Zomig Rapid Melt Tablets, a migraine medication in Japan.
read more
Tuesday, October 31, 2017
Boehringer Ingelheim and Sarah Cannon Research Institute announced an expansion of their partnership to develop novel immuno-oncology therapies
read more